SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jaymin B. Morjaria, Rebecca S. Dickinson, Alyn H. Morice, Novel antitussive strategies, Drug Discovery Today, 2013, 18, 7-8, 380

    CrossRef

  2. 2
    Edward C. Lauterbach, Jeffrey L. Cummings, Preetha Sharone Kuppuswamy, Toward a more precise, clinically—informed pathophysiology of pathological laughing and crying, Neuroscience & Biobehavioral Reviews, 2013, 37, 8, 1893

    CrossRef

  3. 3
    Melanie A. Paquette, Alex A. Martinez, Teresa Macheda, Charles K. Meshul, Steven W. Johnson, S. Paul Berger, Andrea Giuffrida, Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors, European Journal of Neuroscience, 2012, 36, 9
  4. 4
    Aziz I. Shaibani, Laura E. Pope, Ronald Thisted, Adrian Hepner, Efficacy and Safety of Dextromethorphan/Quinidine at Two Dosage Levels for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study, Pain Medicine, 2012, 13, 2
  5. 5
    Linda L. Werling, Ashleigh Keller, Julie G. Frank, Samer J. Nuwayhid, A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder, Experimental Neurology, 2007, 207, 2, 248

    CrossRef

  6. 6
    Linda L. Werling, Edward C. Lauterbach, Ursula Calef, Dextromethorphan as a Potential Neuroprotective Agent With Unique Mechanisms of Action, The Neurologist, 2007, 13, 5, 272

    CrossRef

  7. 7
    Richard Alan Smith, Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability, Expert Opinion on Pharmacotherapy, 2006, 7, 18, 2581

    CrossRef

  8. 8
    Shannon Miller, Dextromethorphan psychosis, dependence and physical withdrawal, Addiction Biology, 2005, 10, 4
  9. 9
    William V. Bobo, Shannon C. Miller, Bryant D. Martin, The Abuse Liability of Dextromethorphan Among Adolescents: A Review, Journal of Child & Adolescent Substance Abuse, 2005, 14, 4, 55

    CrossRef

  10. 10
    Shannon C Miller, Treatment of Dextromethorphan Dependence with Naltrexone, Addictive Disorders & Their Treatment, 2005, 4, 4, 145

    CrossRef

  11. 11
    Jana Sawynok, Allison Reid, Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats, Pain, 2003, 102, 1-2, 179

    CrossRef

  12. 12
    Jana Sawynok, Allison Reid, Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine, European Journal of Pharmacology, 2002, 450, 2, 153

    CrossRef

  13. 13
    Isabel Siegle, Peter Fritz, Klaus Eckhardt, Ulrich M. Zanger, Michel Eichelbaum, Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain, Pharmacogenetics, 2001, 11, 3, 237

    CrossRef

  14. 14
    Hitoshi Ishibashi, Kouichi Kuwano, Kazuo Takahama, Inhibition of the 5-HT1A receptor-mediated inwardly rectifying K+ current by dextromethorphan in rat dorsal raphe neurones, Neuropharmacology, 2000, 39, 12, 2302

    CrossRef

  15. 15
    M Dematteis, G Lallement, M Mallaret, Dextromethorphan and dextrorphan in rats: Common antitussives — Different behavioural profiles, Fundamental & Clinical Pharmacology, 1998, 12, 5